KABC testimony on anti-psychotic drug over-use

In October 2017, the Centers for Medicare and Medicaid Services (CMS) announced that the national anti-psychotic drug reduction goals had been achieved and exceeded by the end of 2016. The national goal was a 30% reduction, and CMS reported a national aggregate reduction of 34.1% (in long-stay residents).

Kansas use rate was 26.1% at the 2011 Quarter 1 baseline; and has a current use rate of 19.8%. 

Kansas is ranked 51st worst nationally.

Read Mitzi McFatrich’s testimony to the Members of House Children and Seniors Committee on February 13, 2018